Processa Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Processa Pharmaceuticals, Inc. (PCSA) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $11.51 million as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-18
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $11.51M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $7.57M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $6.01M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $5.05M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $11.51M 10-K · filed 2026-03-18 |
| 2024-12-31 | $7.57M 10-K · filed 2026-03-18 |
| 2023-12-31 | $6.01M 10-K · filed 2025-03-20 |
| 2022-12-31 | $5.05M 10-K · filed 2024-03-29 |
| 2021-12-31 | $2.62M 10-K · filed 2023-03-30 |
| 2020-12-31 | $1.41M 10-K · filed 2022-03-30 |
| 2019-12-31 | $854.20K 10-K · filed 2021-03-25 |
| 2018-12-31 | $559.82K 10-K · filed 2020-03-06 |
| 2017-12-31 | $49.82K 10-K/A · filed 2019-04-08 |
| 2016-12-31 | $4.45M 10-K · filed 2017-09-25 |
| 2015-12-31 | $4.34M 10-K · filed 2017-09-25 |
| 2014-12-31 | $2.85M 10-K · filed 2017-06-19 |
| 2013-12-31 | $1.88M 10-K · filed 2015-04-14 |
| 2012-12-31 | $1.13M 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |